Osteoarthritis
Welcome,         Profile    Billing    Logout  
 99 Companies   114 Products   114 Products   61 Mechanisms of Action   11 Trials   1875 News 


«12...1617181920212223242526...3637»
  • ||||||||||  Trial completion:  MOLOS: Molecular Microbiology in Osteo-arthritis Infection (clinicaltrials.gov) -  May 29, 2014   
    P=N/A,  N=229, Completed, 
    Trial primary completion date: Jun 2014 --> Dec 2014 Active, not recruiting --> Completed
  • ||||||||||  Trial primary completion date, Surgery:  MIS GEN II: MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty (clinicaltrials.gov) -  May 21, 2014   
    P4,  N=0, Terminated, 
    Trial completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Jul 2007 --> Oct 2007
  • ||||||||||  Enrollment change, Surgery, Pre-surgery:  Effect of Pre-surgery Neuromuscular Physiotherapy (PT) (clinicaltrials.gov) -  May 20, 2014   
    P3,  N=44, Completed, 
    Trial primary completion date: Jul 2007 --> Oct 2007 N=80 --> 44
  • ||||||||||  Trial primary completion date:  Global (clinicaltrials.gov) -  May 19, 2014   
    P=N/A,  N=64, Completed, 
    Recruiting --> Completed Trial primary completion date: Dec 2013 --> Oct 2013
  • ||||||||||  Trial completion date:  Global (clinicaltrials.gov) -  May 19, 2014   
    P=N/A,  N=64, Completed, 
    Trial primary completion date: Dec 2013 --> Oct 2013 Trial completion date: Dec 2013 --> Oct 2013
  • ||||||||||  Trial completion:  Global (clinicaltrials.gov) -  May 19, 2014   
    P=N/A,  N=64, Completed, 
    Trial completion date: Dec 2013 --> Oct 2013 Active, not recruiting --> Completed
  • ||||||||||  Trial primary completion date:  Use of a Novel Fibrin Sealant in Total Knee Arthroplasty (clinicaltrials.gov) -  May 18, 2014   
    P2/3,  N=140, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Trial completion date:  Use of a Novel Fibrin Sealant in Total Knee Arthroplasty (clinicaltrials.gov) -  May 18, 2014   
    P2/3,  N=140, Recruiting, 
    Initiation date: Apr 2011 --> Jun 2012 Trial completion date: Jan 2015 --> Jan 2016
  • ||||||||||  rofecoxib (TRM-201) / Tremeau Pharma
    Trial termination:  12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003) (clinicaltrials.gov) -  May 14, 2014   
    P2,  N=49, Terminated, 
    Trial completion date: Dec 2014 --> Mar 2015 Completed --> Terminated
  • ||||||||||  Clinical:  TC-A Registration Study (clinicaltrials.gov) -  May 13, 2014   
    P=N/A,  N=156, Not yet recruiting, 
  • ||||||||||  Trial withdrawal:  Post-Market Study of the ICONACY Hip System (clinicaltrials.gov) -  May 11, 2014   
    P=N/A,  N=0, Withdrawn, 
    Completed --> Terminated Recruiting --> Withdrawn
  • ||||||||||  Enrollment change:  Post-Market Study of the ICONACY Hip System (clinicaltrials.gov) -  May 11, 2014   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Withdrawn N=87 --> 0
  • ||||||||||  Trial primary completion date:  Effects of Bracing on Knee Osteoarthritis (OA) (clinicaltrials.gov) -  May 8, 2014   
    P=N/A,  N=25, Completed, 
    N=87 --> 0 Trial primary completion date: Aug 2014 --> May 2014
  • ||||||||||  Trial initiation date:  Effects of Bracing on Knee Osteoarthritis (OA) (clinicaltrials.gov) -  May 8, 2014   
    P=N/A,  N=25, Completed, 
    Trial primary completion date: Aug 2014 --> May 2014 Initiation date: Apr 2013 --> Jul 2013
  • ||||||||||  Trial completion:  Effects of Bracing on Knee Osteoarthritis (OA) (clinicaltrials.gov) -  May 8, 2014   
    P=N/A,  N=25, Completed, 
    Initiation date: Apr 2013 --> Jul 2013 Recruiting --> Completed
  • ||||||||||  Trial completion:  Exercise and Steroid in Knee Osteoarthritis (clinicaltrials.gov) -  May 4, 2014   
    P=N/A,  N=100, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Belbuca (buprenorphine BEMA) / Collegium Pharma
    Trial primary completion date:  Long-term Open-Label Safety Study to Evaluate EN3409 (clinicaltrials.gov) -  May 1, 2014   
    P3,  N=200, Recruiting, 
    Trial completion date: Mar 2014 --> Jul 2014 Trial primary completion date: Jan 2014 --> Jun 2015
  • ||||||||||  Belbuca (buprenorphine BEMA) / Collegium Pharma
    Trial completion date:  Long-term Open-Label Safety Study to Evaluate EN3409 (clinicaltrials.gov) -  May 1, 2014   
    P3,  N=200, Recruiting, 
    Trial primary completion date: Jan 2014 --> Jun 2015 Trial completion date: Jan 2014 --> Jun 2015